Kalaris Therapeutics, Inc.

KLRS·NASDAQ·$5.21Share Price as of 11/2·$97MMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2608/11/26 10-QQ1 ended 03/31/2605/12/26 10-KFY 202503/17/26 10-QQ3 ended 09/30/2511/12/25 10-QQ2 ended 06/30/2508/13/25

Disclosures

8-KCurrent report08/11/26 8-KCurrent report07/20/26 8-KCurrent report07/17/26 8-KCurrent report07/06/26 8-KCurrent report06/04/26

Prospectuses and Registrations

424B3Prospectus04/13/26 424B3Prospectus04/13/26 S-3Shelf registration04/03/26 S-3Shelf registration04/03/26 S-8Registration of securities for employees03/17/26

Proxies

DEF 14ADefinitive proxy04/24/26 DEFA14AAdditional proxy materials04/24/26 DEF 14ADefinitive proxy07/01/25 DEFA14AAdditional proxy materials07/01/25 DEF 14ADefinitive proxy12/06/24

Ownership

SC 13GBeneficial ownership10/26/26 Form 4Insider transaction08/28/26 Form 3Initial insider ownership08/03/26 Form 4Insider transaction08/03/26 Form 3Initial insider ownership07/27/26

Other

ARSAnnual report to shareholders04/24/26 EFFECTRequest for effectiveness04/13/26 EFFECTRequest for effectiveness04/13/26 CORRESPCorrespondence with the SEC04/09/26 CORRESPCorrespondence with the SEC04/09/26